Clinical Trials Browser

Phase 3 × INDUSTRY × sulindac sulfone × Clear all

NCT00085826 2011-10-20

A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms